Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR
Authors:
- Juan ZhangJZJuan Zhang
- Haizhen JinHJHaizhen Jin
- Zhiguo ChenZCZhiguo Chen
- Qinhang WuQWQinhang Wu
- Weiguang LiWLWeiguang Li
- Ming YueMYMing Yue
- Chen LuoCLChen Luo
- Min WangMWMin Wang
- 1 October 2013
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 67 (8) , 737-743
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX studyThe Lancet Oncology, 2012
- Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor RecyclingJournal of Biological Chemistry, 2011
- Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinomaCancer, 2011
- A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximabJournal of Biotechnology, 2010
- Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor ConformationCancer Research, 2009
- Interaction of antibodies with ErbB receptor extracellular regionsExperimental Cell Research, 2009
- Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human CancerJournal of Clinical Oncology, 2008
- Structural Basis for EGF Receptor Inhibition by the Therapeutic Antibody IMC-11F8Structure, 2008
- Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer TherapyThe Journal of Immunology, 2004
- The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabodyBiochemical and Biophysical Research Communications, 2004